Both in Surgical Instruments
Anika Therapeutics vs TriSalus Life Sciences
Over the past year ANIK returned +96.3% and TLSI returned −24.8%; their daily moves had a correlation of 0.11.
ANIK +96.3% TLSI −24.8%Growth of $1, one year, split-adjusted
| Metric | ANIK | TLSI |
|---|---|---|
| Price | $19.28 | $3.54 |
| Market cap | $258.0M | $218.0M |
| Today | −0.67% | −2.48% |
| 1 month | −2.3% | −19.2% |
| 6 months | +29.0% | −23.2% |
| Year to date | +100.6% | −49.3% |
| 1 year | +97.7% | −25.3% |
| Revenue growth (YoY) | +15.6% | +1.7% |
| Gross margin | 65.1% | 86.8% |
| Net margin | 10.1% | −80.5% |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | 4.8× |
| Net cash | $38.4M | $13.2M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 46.4% |
| Short % of float | 3.2% | 8.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).